Different types of FCgamma-receptors are involved in anti-Lewis Y antibody induced effector functions in vitro
- PMID: 10646902
- PMCID: PMC2363301
- DOI: 10.1054/bjoc.1999.0940
Different types of FCgamma-receptors are involved in anti-Lewis Y antibody induced effector functions in vitro
Abstract
Stimulation of monocytes by interaction of monoclonal antibodies (mAbs) with Fc gamma receptors (FcgammaRs) results in the activation of various monocyte effector functions. In the present investigation we show that the anti-Lewis Y (LeY) anti-tumour mAb ABL 364 and its mouse/human IgG1 chimaera induce both antibody-dependent cellular cytotoxicity (ADCC) and the release of tumour necrosis factor alpha (TNF-alpha) during mixed culture of monocytes with LeY+ SKBR5 breast cancer cells in vitro. Although anti-LeY mAb-mediated TNF-alpha release paralleled ADCC activity, cytokine release required a higher concentration of sensitizing mAb than the induction of cytolysis. The determination of the FcgammaR classes involved in the induction of the distinct effector functions showed that anti-LeY mAb-induced cytolysis was triggered by interaction between anti-LeY mAbs and FcgammaRI. In contrast, mAb-induced TNF-alpha release mainly depended on the activation of monocyte FcgammaRII. Neutralization of TNF-alpha showed no influence on monocyte ADCC activity towards SKBR5 target cells. Our data indicate an independent regulation of anti-LeY mAb induced effector functions of ADCC and TNF-alpha release which seemed to be triggered by activation of different types of FcgammaR.
Similar articles
-
Induction of tumor necrosis factor alpha production by adhered human monocytes: a key role for Fcgamma receptor type IIIa in rheumatoid arthritis.Arthritis Rheum. 2000 Mar;43(3):608-16. doi: 10.1002/1529-0131(200003)43:3<608::AID-ANR18>3.0.CO;2-G. Arthritis Rheum. 2000. PMID: 10728755
-
Human monocyte-mediated cytotoxicity towards erythrocytes induced by hybrid mouse monoclonal antibodies: effect of antibody binding valency on IgG-Fc gamma R interaction.Immunology. 1992 Feb;75(2):336-42. Immunology. 1992. PMID: 1532380 Free PMC article.
-
Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.Clin Cancer Res. 1996 Sep;2(9):1523-31. Clin Cancer Res. 1996. PMID: 9816329
-
FcgammaR: The key to optimize therapeutic antibodies?Crit Rev Oncol Hematol. 2007 Apr;62(1):26-33. doi: 10.1016/j.critrevonc.2006.12.003. Epub 2007 Jan 19. Crit Rev Oncol Hematol. 2007. PMID: 17240158 Review.
-
Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies.Cancer Metastasis Rev. 2005 Dec;24(4):487-99. doi: 10.1007/s10555-005-6192-2. Cancer Metastasis Rev. 2005. PMID: 16408158 Review.
Cited by
-
Adoptive T-cell therapy for Leukemia.Mol Cell Ther. 2014 Aug 12;2:25. doi: 10.1186/2052-8426-2-25. eCollection 2014. Mol Cell Ther. 2014. PMID: 26056592 Free PMC article. Review.
-
Antibodies: At The Nexus of Antigens and Cancer Vaccines.J Infect Dis. 2015 Jul 15;212 Suppl 1(Suppl 1):S59-66. doi: 10.1093/infdis/jiu638. J Infect Dis. 2015. PMID: 26116735 Free PMC article. Review.
-
Effects of complement and serum IgG on rituximab-dependent natural killer cell-mediated cytotoxicity against Raji cells.Oncol Lett. 2019 Jan;17(1):339-347. doi: 10.3892/ol.2018.9630. Epub 2018 Oct 29. Oncol Lett. 2019. PMID: 30655772 Free PMC article.
-
Genetics Insight for COVID-19 Susceptibility and Severity: A Review.Front Immunol. 2021 Apr 1;12:622176. doi: 10.3389/fimmu.2021.622176. eCollection 2021. Front Immunol. 2021. PMID: 33868239 Free PMC article. Review.
-
Correlation of ADCC activity with cytokine release induced by the stably expressed, glyco-engineered humanized Lewis Y-specific monoclonal antibody MB314.MAbs. 2012 Jul-Aug;4(4):532-41. doi: 10.4161/mabs.20577. Epub 2012 Jul 1. MAbs. 2012. PMID: 22665069 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous